Skip to Content

Join the 'Breast Cancer' group to help and get support from people like you.

Breast Cancer News

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

Yoga May Bring Better Sleep to Breast Cancer Patients

Posted 2 days 8 hours ago by Drugs.com

FRIDAY, Sept. 22, 2017 – A certain type of yoga may provide lasting benefits for breast cancer patients who have trouble sleeping, researchers report. The study included 227 women undergoing chemotherapy for breast cancer who were randomly assigned to one of three groups. One group practiced Tibetan yoga at least twice a week, another group did a simple stretching program, and the third group received usual care (the "control" group). The study participants were assessed one week after the end of the program, and the researchers followed up with them at three, six and 12 months later. Women in the yoga group reported fewer sleep problems and less daytime drowsiness over the long term than those in the other two groups, the researchers said. Sleep problems and fatigue are common among cancer patients undergoing chemotherapy, said study author Lorenzo Cohen. He is director of the ... Read more

Related support groups: Sleep Disorders, Insomnia, Fatigue, Breast Cancer, Breast Cancer, Prevention

Survey: 9 of 10 Americans Take Cancer Prevention Steps

Posted 2 days 8 hours ago by Drugs.com

FRIDAY, Sept. 22, 2017 – About 95 percent of Americans take some action to prevent cancer, according to a new survey. Three-quarters of respondents said they don't smoke; 74 percent limit their alcohol consumption; 72 percent stick to a healthy diet; and 90 percent are aware of their family's cancer history, the survey found. Women are far more likely than men to take all three preventive steps and more – discussing risk and prevention with their health care provider, getting the recommended amount of sleep, and undergoing recommended cancer screenings. The fourth edition of the Mayo Clinic National Health Checkup also reported that 62 percent said they or a loved one had been diagnosed with cancer. Sixty-one percent are concerned that they will develop cancer during their lifetime. Despite the concern, many respondents have an optimistic attitude: 78 percent expect a cure for cancer ... Read more

Related support groups: Cancer, Smoking, Breast Cancer, Smoking Cessation, Lung Cancer, Colorectal Cancer

Cancer Treatment Can Affect Your Food Preferences

Posted 5 days ago by Drugs.com

TUESDAY, Sept. 19, 2017 – Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert. "Increased taste sensitivities are more common than a muting of taste," said Catherine Carpenter, professor of clinical nutrition at UCLA's David Geffen School of Medicine. "Usually, the type of taste sensitivity encountered is one of a metallic nature." Changes in tastes often influence a person's food preferences, but treatment may affect individuals differently, Carpenter noted in a university news release. "If anything, patients tend to prefer bland foods rather than spicy foods," she said. "It's important to remember that preferences may vary depending on the cancer and type of treatment. You cannot lump all cancer patients into one dietary regimen." After treatments, such as chemo or radiation therapy, a nutritionist can help ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Oral and Dental Conditions, Xerostomia, Fluorouracil, Colorectal Cancer, Xeloda, Hydroxyurea, Nausea/Vomiting - Chemotherapy Induced, Mercaptopurine, Hydrea, Capecitabine, Dacogen, Gemzar, Gemcitabine, Alimta, Decitabine, Cladribine, Folotyn

Surgeons Play Big Role in Women's Choices for Breast Cancer Care

Posted 11 days ago by Drugs.com

WEDNESDAY, Sept. 13, 2017 – A breast cancer patient's choice of surgeon can have a major effect on her treatment, according to a new study. That's because surgeons have a strong influence on whether early stage cancer patients have both breasts removed even when cancer is found in only one breast – a procedure called contralateral prophylactic mastectomy (CPM). Researchers surveyed more than 3,300 women with early stage breast cancer and 349 surgeons who treated them. About 16 percent of the patients had both breasts removed. Only 4 percent of those whose surgeons heavily favored breast-saving surgery and were most reluctant to remove both breasts had the procedure. That compared to 34 percent of patients whose surgeons were most willing to do the surgery, the study found. "That difference is huge. Even for a procedure that is very patient-driven, we see that surgeons account for a ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Palliative

Many May Get Hospice Care Too Late

Posted 12 days ago by Drugs.com

TUESDAY, Sept. 12, 2017 – Despite a growing list of debilitating symptoms during the final months of life, most seniors never receive end-of-life hospice care – or they delay doing so until their last few weeks of life, new research finds. "The main message is that the duration of hospice is very short," explained lead study author Dr. Thomas Gill. This, despite the fact that his team "documented high rates of distressing symptoms well before the start of hospice." Gill is the director of the Yale University Program on Aging. "Since hospice is designed to help alleviate distressing symptoms – including pain, nausea and anxiety, among others – our findings suggest that health care providers might need to consider discussing referrals to hospice sooner with older persons who are approaching the end of their lives," Gill added. The National Hospice and Palliative Care Organization ... Read more

Related support groups: Cancer, Breast Cancer, Dementia, Prostate Cancer, Alzheimer's Disease, Lung Cancer, Colorectal Cancer, Mild Cognitive Impairment, Solid Tumors, Lewy Body Dementia

Breast Cancer Patients On Opioid Treatment More Likely To Discontinue Hormones

Posted 13 days ago by Drugs.com

MONDAY, Sept. 11, 2017 – Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report. Use of prescription opioids such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found. "It's not a big secret that the U.S. uses more opioids than any other country in the world," said researcher Rajesh Balkrishnan, of the University of Virginia School of Medicine's department of public health sciences. "Clearly there has to be better management of opioids in the elderly cancer population," Balkrishnan said in a university news release. For the study, researchers analyzed follow-through rates for adjuvant endocrine therapy – commonly called hormone treatment – among more than ... Read more

Related support groups: OxyContin, Breast Cancer, Tamoxifen, Arimidex, Breast Cancer, Metastatic, Anastrozole, Vicoprofen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nolvadex, Tamoxifen Hexal, Tamone, Emblon, Tamoxen, Tamofen, Tamosin, Genox, Nolvadex D, Soltamox

Obamacare Paid Off for Poorer Cancer Patients

Posted 14 days ago by Drugs.com

FRIDAY, Sept. 8, 2017 – The percentage of poor, newly diagnosed cancer patients without health insurance fell in states that expanded Medicaid under the Affordable Care Act (ACA) but remained high elsewhere, according to a new study. The American Cancer Society study also found a small increase in early stage diagnosis of some common cancers in Medicaid-expansion states. "The small shift toward early stage diagnosis for select common cancers, particularly in Medicaid expansion states, adds to the existing evidence on the positive effects of the Affordable Care Act on improving access to and quality of care in low-income population," wrote the researchers led by Dr. Ahmedin Jemal, vice president of surveillance and health services research at the American Cancer Society. The ACA – also known as Obamacare – allowed states to expand Medicaid coverage to a large group of low-income ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer

'Cancer Pen' Could Help Surgeons Spot Tumor Cells in Seconds

Posted 18 days ago by Drugs.com

WEDNESDAY, Sept. 6, 2017 – A new "cancer pen" promises to help surgeons immediately detect and completely remove cancerous tumor tissue, without having to send samples off to a lab for testing while the patient languishes on the table. The MasSpec Pen is a hand-held device that allows doctors to test in real-time whether tissue is cancerous or not, delivering results in about 10 seconds, researchers report. The pen will make it easier to surgically clear out all the cancer cells surrounding a tumor, explained senior researcher Livia Eberlin, an assistant professor of chemistry with the University of Texas at Austin. In particular, cancers such as those of the breast, pancreas and brain "tend to invade surrounding normal tissue," Eberlin said. "For a surgeon, it can be really tricky, because these cells resemble normal tissue. Just judging by [the] eye, it can be very challenging." The ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Brain Tumor, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation

Science Weighs in On How Fat Raises Cancer Risk

Posted 1 Sep 2017 by Drugs.com

FRIDAY, Sept. 1, 2017 – Scientists have known for years that obesity can rise cancer risk, but how? Now, new research offers clues to how fat cells encourage tumors. The issue is an important one, the study author said. "Obesity is increasing dramatically worldwide, and is now also recognized as one of the major risk factors for cancer, with 16 different types of cancer linked to obesity," explained Cornelia Ulrich, of the Huntsman Cancer Institute in Salt Lake City. To help prevent the disease, "we urgently need to identify the specific mechanisms that link obesity to cancer," she said. Prior studies have already outlined several ways fat could play a role in cancer. For example, obesity increases inflammation in the body, which has long been associated with the disease. Obesity can also affect cancer cell metabolism and undermine the immune system's natural defenses, which may help ... Read more

Related support groups: Obesity, Cancer, Breast Cancer, Colorectal Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

Faslodex (fulvestrant) Receives FDA Approval as Monotherapy for Expanded Use in HR+, HER2- Advanced Breast Cancer

Posted 29 Aug 2017 by Drugs.com

August 28, 2017 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Faslodex (fulvestrant) 500mg as monotherapy for expanded use in women with hormone-receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer, who have gone through menopause and have not received previous endocrine therapy.1 The FDA approval is based on pivotal data from the Phase III FALCON trial, which were published in the November 2016 issue of The Lancet.2 Jamie Freedman, Executive Vice President, Head of the Oncology Business Unit, AstraZeneca said: “We’re pleased that the landmark FALCON trial results demonstrated the efficacy of Faslodex as initial monotherapy treatment for women who are living with HR+, HER2- advanced breast cancer. This approval, building on more than 15 years of clinical experience, means more patients c ... Read more

Related support groups: Breast Cancer, Faslodex, Fulvestrant

Study Supports Annual Mammograms Starting at Age 40

Posted 21 Aug 2017 by Drugs.com

MONDAY, Aug. 21, 2017 – How frequently should women get a mammogram? Guidelines differ, but a new study estimates thousands of U.S. lives could be saved if mammograms were done every year from age 40 to 84. "Screening annually starting at age 40 is the best strategy to avert an early breast cancer death," said study co-author R. Edward Hendrick, a radiology professor at the University of Colorado School of Medicine. In the United States, more than 40,600 women will die from breast cancer this year alone, according to the American Cancer Society. And about 252,700 new cases of invasive breast cancer will be diagnosed. Hendrick and his colleagues used computer modeling to assess the three major mammogram recommendations: annual screening from age 40 to 84; annual screening at ages 45 to 54, then every other year from 55 to 79; or every other year from 50 to 74. "We know that screening ... Read more

Related support groups: Breast Cancer, Breast Cancer, Prevention, Diagnosis and Investigation, Body Imaging

Could Urban Lighting Raise Breast Cancer Risk for Some Women?

Posted 18 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – New research reveals an unexpected potential risk factor for breast cancer: city lights. The Harvard Medical School study found an association between living in areas with high amounts of ambient nighttime light and slightly increased odds for breast cancer in younger women who smoke. "In our modern industrialized society, artificial lighting is nearly ubiquitous. Our results suggest that this widespread exposure to outdoor lights during nighttime hours could represent a novel risk factor for breast cancer," study author Peter James said in a Harvard news release. He's assistant professor of population medicine at Harvard's Pilgrim Health Care Institute. As the investigators explained, earlier research had suggested that high levels of exposure to light at night disrupts the body's internal clock. In turn, that might lower levels of a hormone called melanin ... Read more

Related support groups: Sleep Disorders, Smoking, Breast Cancer, Smoking Cessation, Breast Cancer, Prevention

Can a Blood Test Detect a Range of Cancers Earlier?

Posted 16 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 16, 2017 – A new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late, a new study suggests. The test scans blood for DNA fragments released by cancerous tumors, explained lead researcher Dr. Victor Velculescu. By reviewing these DNA fragments for mutations found in 58 "cancer-driver" genes, the blood test detects many early stage cancers without rendering false positives for healthy people, said Velculescu, co-director of cancer biology at the Johns Hopkins Kimmel Cancer Center, in Baltimore. The test detected stage 1 or 2 colon, breast, lung or ovarian cancers between 59 percent and 71 percent of the time when assessing 200 patients previously diagnosed with cancer, researchers found. "If we are able to detect cancer earlier, our chances of saving lives would be much higher," Velculescu said. "The survival ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Diagnosis and Investigation

Heart Risks May Rise After Cancer Diagnosis

Posted 15 Aug 2017 by Drugs.com

TUESDAY, Aug. 15, 2017 – As if people newly diagnosed with cancer don't have enough to worry about, a new study suggests the diagnosis may put their hearts at risk, too. The study found that newly diagnosed cancer patients are at increased risk for a condition called arterial thromboembolism, which occurs when blood flow is blocked by a clot that's traveled from another part of the body, such as the legs. The potential heart threat is higher "especially during the first six months after diagnosis," said a team led by Dr. Babak Navi, of Weill Cornell Medicine's department of neurology in New York City. Looking through a 2002-2011 database of about 140,000 cancer patients and an equal number of people without cancer, Navi's team found that cancer patients had twice the risk of an arterial thromboembolism in the six months after cancer diagnosis than patients without cancer. The study ... Read more

Related support groups: Cancer, Ischemic Stroke, Breast Cancer, Heart Attack, Lipitor, Simvastatin, Crestor, Atorvastatin, Pravastatin, Transient Ischemic Attack, Lung Cancer, Colorectal Cancer, Zocor, Lovastatin, Myocardial Infarction, Rosuvastatin, Pravachol, Livalo, Red Yeast Rice, Ischemic Stroke - Prophylaxis

Antiperspirant Use Seems Safe During Breast Cancer Treatment: Study

Posted 11 Aug 2017 by Drugs.com

FRIDAY, Aug. 11, 2017 – Contrary to what some doctors might say, new research suggests it's OK to use antiperspirants while undergoing radiation therapy for breast cancer. Researchers surveyed 92 patients and found that 79 percent said their doctors had told them not to use antiperspirants during treatment. And a survey of 105 doctors and nurses found that 82 percent said they regularly told breast cancer patients not to use antiperspirants during radiation therapy. The reason for the warning is the fear that antiperspirant use could lead to greater radiation damage to the skin, according to the study authors. The University of Pennsylvania researchers conducted laboratory tests and found no difference in the radiation dose absorbed – whether or not patients used antiperspirants. The study was published online recently in the journal Radiotherapy and Oncology. "Going without ... Read more

Related support groups: Hyperhidrosis, Breast Cancer, Drysol, Hypercare, Breast Cancer - Adjuvant, Aluminum Chloride Hexahydrate, Certain Dri, Xerac AC, History - Radiation Therapy, B+Drier

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Cancer

Related Drug Support Groups

methotrexate, tamoxifen, Arimidex, fluorouracil, Femara, anastrozole, letrozole, Xeloda, Herceptin, view more... Aromasin, Afinitor, Taxol, exemestane, Taxotere, Cytoxan, cyclophosphamide, capecitabine, Faslodex, Ibrance, paclitaxel, Gemzar, doxorubicin, gemcitabine, Adriamycin, vinblastine, Menest, docetaxel, eribulin, everolimus, Tykerb, Durabolin, bevacizumab, Abraxane, Kadcyla, Perjeta, Fareston, Velban, Deca-Durabolin, Kisqali, fulvestrant, Neosar, lapatinib, Cytadren, Tamoxifen Hexal, Durabolin 50, Methotrexate LPF Sodium, Ixempra, nandrolone, thiotepa, trastuzumab, pertuzumab, Adrucil, esterified estrogens, Trexall, Nolvadex, Anabolin LA, Hybolin-Improved, Hybolin Decanoate, Tepadina, Andryl 200, Androlone-D, fluoxymesterone, Docefrez, Adriamycin PFS, Halaven, Estratab, paclitaxel protein-bound, Tamosin, Halotestin, Cytoxan Lyophilized, Androxy, letrozole / ribociclib, ribociclib, palbociclib, Onxol, ado-trastuzumab emtansine, ixabepilone, Soltamox, Folex PFS, toremifene, Adriamycin RDF, Tamone, Emblon, Tamofen, Nolvadex D, Genox, Tamoxen, Thioplex, aminoglutethimide